These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
826 related items for PubMed ID: 19766886
1. Treatment options for nosocomial pneumonia due to MRSA. Niederman MS. J Infect; 2009 Sep; 59 Suppl 1():S25-31. PubMed ID: 19766886 [Abstract] [Full Text] [Related]
2. Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus. Maclayton DO, Hall RG. Ann Pharmacother; 2007 Feb; 41(2):235-44. PubMed ID: 17299012 [Abstract] [Full Text] [Related]
3. European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid. Chastre J, Blasi F, Masterton RG, Rello J, Torres A, Welte T. Clin Microbiol Infect; 2014 Apr; 20 Suppl 4():19-36. PubMed ID: 24580739 [Abstract] [Full Text] [Related]
4. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid. Stein GE, Wells EM. Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750 [Abstract] [Full Text] [Related]
5. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance. Werarak P, Kiratisin P, Thamlikitkul V. J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567 [Abstract] [Full Text] [Related]
6. Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia: implications of the ZEPHyR trial. Alaniz C, Pogue JM. Ann Pharmacother; 2012 Oct; 46(10):1432-5. PubMed ID: 22947593 [Abstract] [Full Text] [Related]
7. Management of methicillin-resistant Staphylococcus aureus pneumonia. Luna CM, Boyeras Navarro ID. Curr Opin Infect Dis; 2010 Apr; 23(2):178-84. PubMed ID: 20075728 [Abstract] [Full Text] [Related]
9. Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus. Estes L, Orenstem R. Clin Ther; 2007 Apr; 29(4):759-60; author reply 760-1. PubMed ID: 17617300 [No Abstract] [Full Text] [Related]
11. Pharmacotherapy for methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Segarra-Newnham M, Church TJ. Ann Pharmacother; 2012 Dec; 46(12):1678-87. PubMed ID: 23232021 [Abstract] [Full Text] [Related]
12. Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus. Puzniak LA, Morrow LE, Huang DB, Barreto JN. Clin Ther; 2013 Oct; 35(10):1557-70. PubMed ID: 24011955 [Abstract] [Full Text] [Related]
13. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Wunderink RG, Niederman MS, Kollef MH, Shorr AF, Kunkel MJ, Baruch A, McGee WT, Reisman A, Chastre J. Clin Infect Dis; 2012 Mar 01; 54(5):621-9. PubMed ID: 22247123 [Abstract] [Full Text] [Related]
14. The ZEPHyR study: a randomized comparison of linezolid and vancomycin for MRSA pneumonia. Chavanet P. Med Mal Infect; 2013 Dec 01; 43(11-12):451-5. PubMed ID: 24238896 [Abstract] [Full Text] [Related]
15. Antimicrobial treatment of nosocomial meticillin-resistant Staphylococcus aureus (MRSA) pneumonia: current and future options. Welte T, Pletz MW. Int J Antimicrob Agents; 2010 Nov 01; 36(5):391-400. PubMed ID: 20724119 [Abstract] [Full Text] [Related]